Literature DB >> 8956795

Breast carcinomas occurring in young women (< 35 years) are different.

R A Walker1, E Lees, M B Webb, S J Dearing.   

Abstract

One hundred and sixty-three breast carcinomas occurring in women aged between 26 and 44 years were examined for pathological features, oestrogen and progesterone receptor status, proliferation as determined by Ki-67 labelling and the presence of c-erbB-2 and p53 protein, and were compared with a control group of carcinomas from women in the 50-67 years age group. Carcinomas occurring in women aged under 35 years had a significantly high incidence of being poorly differentiated and of having high proliferation rates. This group also had a significantly high incidence of p53 protein staining. Carcinomas in the under 30 years age group had a lower incidence of oestrogen and progesterone receptor positivity. No differences were found in c-erbB-2-positive staining between the groups. Infiltrating lobular carcinomas were only identified in women aged 40 years and over. There was a higher incidence of a family history in the 35-44 years age group (18%) than in the under 35 years age group (11%). Breast carcinomas occurring in women aged under 35 years are more aggressive. An important finding is the high incidence of p53 positivity, which may indicate genetic instability.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8956795      PMCID: PMC2077218          DOI: 10.1038/bjc.1996.632

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  33 in total

1.  Carcinoma of the breast in women under 30 years of age: a clinical and histopathological study of all cases reported as carcinoma to the Swedish Cancer Registry, 1958-1968.

Authors:  A Wallgren; C Silfverswärd; A Hultborn
Journal:  Cancer       Date:  1977-08       Impact factor: 6.860

2.  Age as a prognostic factor in breast cancer.

Authors:  H Høst; E Lund
Journal:  Cancer       Date:  1986-06-01       Impact factor: 6.860

3.  Prognostic value of estrogen and progesterone receptors measured by enzyme immunoassays in human breast tumor cytosols.

Authors:  J A Foekens; H Portengen; W L van Putten; H A Peters; H L Krijnen; J Alexieva-Figusch; J G Klijn
Journal:  Cancer Res       Date:  1989-11-01       Impact factor: 12.701

4.  Immunocytochemical localization of estrogen and progesterone receptor and prognosis in human primary breast cancer.

Authors:  A Reiner; B Neumeister; J Spona; G Reiner; M Schemper; R Jakesz
Journal:  Cancer Res       Date:  1990-11-01       Impact factor: 12.701

5.  The relation between survival and age at diagnosis in breast cancer.

Authors:  H O Adami; B Malker; L Holmberg; I Persson; B Stone
Journal:  N Engl J Med       Date:  1986-08-28       Impact factor: 91.245

6.  Breast cancer in women aged 30 and under.

Authors:  R D Noyes; W J Spanos; E D Montague
Journal:  Cancer       Date:  1982-03-15       Impact factor: 6.860

7.  Histopathological characteristics and oestrogen receptor content in primary breast carcinoma.

Authors:  B B Rasmussen; C Rose; S M Thorpe; K Hou-Jensen; J L Daehnfeldt; T Palshof
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1981

8.  Younger women with breast carcinoma have a poorer prognosis than older women.

Authors:  M Chung; H R Chang; K I Bland; H J Wanebo
Journal:  Cancer       Date:  1996-01-01       Impact factor: 6.860

9.  An evaluation of immunoreactivity for c-erbB-2 protein as a marker of poor short-term prognosis in breast cancer.

Authors:  R A Walker; W J Gullick; J M Varley
Journal:  Br J Cancer       Date:  1989-09       Impact factor: 7.640

10.  Comparison of monoclonal antibody Ki-67 reactivity with grade and DNA flow cytometry of breast carcinomas.

Authors:  R A Walker; R S Camplejohn
Journal:  Br J Cancer       Date:  1988-03       Impact factor: 7.640

View more
  48 in total

1.  Prognosis in very young women with triple-negative breast cancer: retrospective study of 216 cases.

Authors:  Ying Liu; Tao Xin; Da-yong Huang; Wei-xi Shen; Li Li; Yan-ju Lv; Ying-hua Jin; Xiao-wei Song; Chong Teng; Qiu-ying Jiang
Journal:  Med Oncol       Date:  2014-11-13       Impact factor: 3.064

2.  Mammographic appearance of nonpalpable breast cancer reflects pathologic characteristics.

Authors:  Csaba Gajdos; Paul Ian Tartter; Ira J Bleiweiss; George Hermann; John de Csepel; Alison Estabrook; Alfred W Rademaker
Journal:  Ann Surg       Date:  2002-02       Impact factor: 12.969

3.  Contralateral prophylactic mastectomy in young women with breast cancer: a population-based analysis of predictive factors and clinical impact.

Authors:  A Bouchard-Fortier; N N Baxter; R Sutradhar; K Fernandes; X Camacho; P Graham; M L Quan
Journal:  Curr Oncol       Date:  2018-12-01       Impact factor: 3.677

4.  Risk factors and natural history of breast cancer in younger Chinese women.

Authors:  Winnie Yeo; Hang-Mei Lee; Amy Chan; Emily Yy Chan; Miranda Cm Chan; Keeng-Wai Chan; Sharon Ww Chan; Foon-Yiu Cheung; Polly Sy Cheung; Peter Hk Choi; Josette Sy Chor; William Wl Foo; Wing-Hong Kwan; Stephen Ck Law; Lawrence Pk Li; Janice Wh Tsang; Yuk Tung; Lorna Ls Wong; Ting-Ting Wong; Chun-Chung Yau; Tsz-Kok Yau; Benny Cy Zee
Journal:  World J Clin Oncol       Date:  2014-12-10

5.  Is breast cancer in young Asian women more aggressive than in Caucasians? A cross-sectional analysis.

Authors:  Muy-Kheng M Tea; Lei Fan; James W Delancey; Christine Staudigl; Stefan Steurer; Christina Lang; Zhi-Ming Shao; Christian F Singer
Journal:  Tumour Biol       Date:  2013-04-13

6.  Distinct clinicopathological features and prognosis of emerging young-female breast cancer in an East Asian country: a nationwide cancer registry-based study.

Authors:  Ching-Hung Lin; Po-Ya Chuang; Chun-Ju Chiang; Yen-Shen Lu; Ann-Lii Cheng; Wen-Hung Kuo; Chiun-Sheng Huang; Mei-Shu Lai; San-Lin You; Chao-Hsiun Tang
Journal:  Oncologist       Date:  2014-05-07

7.  Breast cancer in moroccan young women: a retrospective study.

Authors:  Halima Abahssain; Issam Lalya; Fatima Zahra El M'rabet; Nabil Ismaili; Rachid Razine; Mohammed Adnane Tazi; Hind M'rabti; Omar El Mesbahi; Nourddine Benjaafar; Redouane Abouqal; Hassan Errihani
Journal:  BMC Res Notes       Date:  2010-11-08

8.  Association of invasion-promoting tenascin-C additional domains with breast cancers in young women.

Authors:  David S Guttery; Rachael A Hancox; Kellie T Mulligan; Simon Hughes; Sinead M Lambe; J Howard Pringle; Rosemary A Walker; J Louise Jones; Jacqueline A Shaw
Journal:  Breast Cancer Res       Date:  2010-08-02       Impact factor: 6.466

9.  Breast cancer in young women: poor survival despite intensive treatment.

Authors:  Hanna Fredholm; Sonja Eaker; Jan Frisell; Lars Holmberg; Irma Fredriksson; Henrik Lindman
Journal:  PLoS One       Date:  2009-11-11       Impact factor: 3.240

10.  Parallel routes of human carcinoma development: implications of the age-specific incidence data.

Authors:  James P Brody
Journal:  PLoS One       Date:  2009-09-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.